Stryker Corporation (SYK) Investor Relations Documents

Stryker Corporation (SYK) investor relations documents from the company's IR site: 3 presentations, 14 press releases; latest deck 2025-11-13. Read in-app with summaries. First-party data.

Investor relations documents — source: company IR site

Published	Type	Document
2026-08-05	Press release	Stryker declares an $0.88 per share quarterly dividend
2026-07-30	Press release	Stryker's Q2 2026 Earnings Call
2026-07-01	Press release	Stryker to announce second quarter 2026 financial results
2026-05-07	Press release	Stryker declares an $0.88 per share quarterly dividend
2026-05-07	Press release	Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular
2026-05-01	Press release	Stryker to participate in the Bank of America Securities 2026 Global Healthcare Conference
2026-04-30	Press release	PRESS RELEASE (opens in new window)
2026-04-13	Press release	Stryker signs definitive agreement to acquire Amplitude Vascular Systems to add next-generation IVL technology to periph
2026-04-01	Press release	Stryker to announce financial results for its first quarter of fiscal year 2026
2026-03-31	Press release	Stryker names Nick Mead Vice President, Investor Relations
2026-03-23	Press release	Stryker announces Annual Meeting of Shareholders
2026-02-04	Press release	Stryker declares an $0.88 per share quarterly dividend
2026-01-29	Press release	Stryker reports 2025 operating results and 2026 outlook (opens in new window)
2026-01-05	Press release	Stryker to announce financial results for its fourth quarter and full year 2025
2025-11-13	Presentation	Market Outlook by Division and Business Unit (opens in new window)
2025-11-13	Presentation	Management Presentation (opens in new window)
2025-01-06	Presentation	Acquisition of Inari Medical
	ESG report	Read now PDF (opens in new window)

SYK overview · SYK earnings · SYK financials · SYK KPIs · SYK ownership · SYK peers · SYK filings

Documents published by the company on its investor-relations site; summaries are model-written. Not personalized investment advice.